Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year
8 years ago
Startups
IL-2 without the toxic side effects? Orbimed backs the idea in Synthorx' $63M round
8 years ago
Startups
What do you get when you integrate healthcare data from multiple sources into one comprehensive, global package? Travis May says he’s on track to find out
8 years ago
Deals
Crescendo snares $70M Series B for its tumor-fighting tech
8 years ago
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
8 years ago
IPO plans brewing, Innovent Biologics raises $150M and eyes hundreds of millions more
8 years ago
Amid hot IPO season, Mereo drops Nasdaq plans citing 'challenging' market conditions
8 years ago
Forget Nasdaq. China’s biotechs with blockbuster IPO dreams are switching focus to Hong Kong
8 years ago
China
Venrock-backed startup Corvidia snags $60M round to develop ex-AstraZeneca drug
8 years ago
After decades in the big leagues, Martin Mackay is going small — and he's delighted
8 years ago
People
Startups
Protein degradation 2.0? Third Rock sinks $56M into Cedilla's unusual approach
8 years ago
Startups
Nextech leads a $56M round for the Revolution's move into the clinic
8 years ago
Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May
8 years ago
China
Biotech unicorn's 'brain' attracts a $115M mega-round as investors embrace AI upstart
8 years ago
AI
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
8 years ago
Kleiner Perkins’ Beth Seidenberg bumps Tmunity’s cell therapy round to a cool $135M
8 years ago
Flagship’s Evelo Biosciences pitches $100M IPO for a new platform of monoclonal microbials
8 years ago
Inventiva raises $44M as it preps for a PhIII NASH program, upcoming IIb readout
8 years ago
Former Novo chairman Göran Ando joins the board as Tessa bags $50M in additional funding
8 years ago
VC believers back a $41M game plan for Enterprise Therapeutics' new group of respiratory drugs
8 years ago
Startups
Tapping a biotech boom, China gene editing CRO Biocytogen bags $65M round for global expansion
8 years ago
Outsourcing
Magenta bags $52M Series C for bone marrow transplant pipeline
8 years ago
Constellation joins the mega-round club with $100M raise and plans to pursue cancer studies
8 years ago
Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
8 years ago
First page
Previous page
130
131
132
133
134
135
136
Next page
Last page